Anna Batarina

Anna Batarina currently works at Baltiiskii Balkernyi Terminal, as Director, Galvanize Therapeutics, Inc., as Director, Ascidian Therapeutics, Inc., as Director, CFA Institute, as Member, Strategic Development Group, Inc., as Vice President, Marengo Therapeutics, Inc., as Board Member, Aulos Bioscience, Inc., as Board Member, Intergalactic Therapeutics, Inc., as Board Member, and Apple Tree Venture Management Llc, as Partner from 2025.
Ms. Batarina also formerly worked at Uralkali PJSC, as Vice President-Investor Relations from 2010 to 2011 and Braeburn, Inc., as Vice President in 2016.
Ms. Batarina received her graduate degree in 2023 from The Johns Hopkins University, graduate degree in 2016 from Yale University, graduate degree in 2011 from Moscow State University Lomonosov, and undergraduate degree in 2002 from Financial University.